Cancer Research AACR Conference on Molecular Diagnostics - 2008  Tumor Immunology: New Perspectives
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online

[Cancer Research 34, 2165-2171, September 1, 1974]
© 1974 American Association for Cancer Research

This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Glaser, M.
Right arrow Articles by Djeu, J. Y.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Glaser, M.
Right arrow Articles by Djeu, J. Y.

Study of the Cellular Immune Response to Gross Virus-induced Lymphoma by the Mixed Lymphocyte-Tumor Interaction

M. Glaser, R. B. Herberman, H. Kirchner and J. Y. Djeu

Cellular and Tumor Immunology Section, Laboratory of Cell Biology, National Cancer Institute, Bethesda, Maryland 20014

A one-way mixed lymphocyte-tumor cell interaction assay was applied to the study of cell-mediated immunity to a syngeneic Gross virus-induced lymphoma, (C58NT)D, in W/Fu rats. Lymphoid cells from the spleens of rats inoculated by the tumor cells were stimulated in vitro by incubation with intact, inactivated tumor cells. Optimal conditions for stimulation were incubation of 6 x 105 spleen cells and 2 x 104 mitomycin C-treated tumor cells for 4 days. Significant stimulation was first detected at 14 days after tumor cell inoculation, reached a peak at Days 20 to 40, and gradually declined to low levels by Day 90. Immunization with from 1 x 105 to 1 x 108 tumor cells induced similar reactivity; 1 x 109 cells produced progressive tumor growth and no reactivity was seen. Treatment of immune spleen cells with specific anti-rat thymocyte serum abolished their response while removal of complement receptor-bearing lymphocytes from the spleens did not reduce the reactivity. Specificity was shown by inability of three other W/Fu rat tumor cells to stimulate (C58NT)D-immune W/Fu spleen cells and by inability of (C58NT)D cells to stimulate spleen cells obtained either from normal W/Fu rats or from W/Fu rats inoculated with another W/Fu tumor.

These results indicate that the one-way mixed lymphocyte tumor cell interaction may measure cellular immunity and not primary recognition of antigens of Gross virus-induced lymphoma and that thymus-processed lymphoid cells are needed for the reactivity in the one-way mixed lymphocyte-tumor cell interaction.

Received 2/ 1/74. Accepted 5/ 7/74.







HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online
Copyright © 1974 by the American Association for Cancer Research.